Related references
Note: Only part of the references are listed.Comparison of Empiric Versus Whole-Body/-Blood Clearance Dosimetry Based Approach to Radioactive Iodine Treatment in Patients with Metastases from Differentiated Thyroid Cancer
Desiree Deandreis et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Assessment of Lesion Response in the Initial Radioiodine Treatment of Differentiated Thyroid Cancer Using 124I PET Imaging
Walter Jentzen et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Life Expectancy Is Reduced in Differentiated Thyroid Cancer Patients >= 45 Years Old with Extensive Local Tumor Invasion, Lateral Lymph Node, or Distant Metastases at Diagnosis and Normal in All Other DTC Patients
Frederik A. Verburg et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Approach to the Patient: Role of Dosimetric RAI Rx in Children With DTC
Frederik A. Verburg et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Strategies of Radioiodine Ablation in Patients with Low-Risk Thyroid Cancer
Martin Schlumberger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Ablation with Low-Dose Radioiodine and Thyrotropin Alfa in Thyroid Cancer
Ujjal Mallick et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Efficacy of Dosimetric Versus Empiric Prescribed Activity of 131I for Therapy of Differentiated Thyroid Cancer
Joanna Klubo-Gwiezdzinska et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Dosimetry and thyroid cancer: the individual dosage of radioiodine
Michael Lassmann et al.
ENDOCRINE-RELATED CANCER (2010)
Dosimetry-guided high-activity 131I therapy in patients with advanced differentiated thyroid carcinoma: initial experience
Frederik A. Verburg et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
No survival difference after successful 131I ablation between patients with initially low-risk and high-risk differentiated thyroid cancer
Frederik Anton Verburg et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
Radioiodine therapy dosimetry in benign thyroid disease and differentiated thyroid carcinoma
Massimo Salvatori et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
Maximal safe dose of I-131 after failure of standard fixed dose therapy in patients with differentiated thyroid carcinoma
Jong Jin Lee et al.
ANNALS OF NUCLEAR MEDICINE (2008)
Guidelines for radioiodine therapy of differentiated thyroid cancer
M. Luster et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2008)
EANM Dosimetry Committee series on standard operational rocedures for pre-therapeutic dosimetry I: blood and bone marrow dosimetry in differentiated thyroid cancer therapy
Michael Lassmann et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2008)
I-124-PET dosimetry in advanced differentiated thyroid cancer: Therapeutic impact
L. S. Freudenberg et al.
NUKLEARMEDIZIN-NUCLEAR MEDICINE (2007)
Share Paper
